PEC

Baron & Budd, Douglas & London, P.C., and Napoli Shkolnik Reach Historic Settlement with 3M Company for PFAS Contamination in America’s Drinking Water

Retrieved on: 
Thursday, June 22, 2023
Class Action Lawsuit, Professional Services, Legal, AFFF, P.C, Interim, Drinking water, PFAS, Public water system, DuPont, The Honourable, Douglas, MDL, District court, PEC, Quantification Settlement Agreement, Health, Environment, PFOS, Cosmetics, Court, Chemours

3M is obligated under this Settlement Agreement to pay a Settlement Amount of up to Twelve Billion Five Hundred Million dollars ($12,500,000,000).

Key Points: 
  • 3M is obligated under this Settlement Agreement to pay a Settlement Amount of up to Twelve Billion Five Hundred Million dollars ($12,500,000,000).
  • This is the largest drinking water settlement in American history.
  • ; Scott Summy of Baron Budd; and Paul J. Napoli of Napoli Shkolnik – consider this settlement to be in the best interests of the proposed class.
  • This agreement represents the first of many steps to begin to redress the harms of PFAS contamination in America’s drinking water supplies.

PRODUCTLIFE GROUP ANNOUNCES ITS INTENTION TO MERGE WITH PHARMA D&S GROUP, EXPANDING ITS OVERALL OFFERING AND ITALIAN FOOTPRINT

Retrieved on: 
Wednesday, June 7, 2023
DNA, Pharma, Engineering, Medication, Computer, Organization, Biotechnology, PEC, Acquisition, Medtech, Growth, Regulatory affairs, PLG, Fine chemical, Pharmacovigilance

PARIS and FLORENCE, Italy, June 7, 2023 /PRNewswire/ -- ProductLife Group (PLG), the global and specialized provider of regulatory, vigilance and quality management services for the Pharmaceutical, Biotech and Medtech industries, announces its intention to merge with Pharma D&S Group, the leading Italian player in the industry.

Key Points: 
  • ProductLife Group is reaching a key step in its growth with the acquisition of privately owned Italian company Pharma D&S Group.
  • With more than two hundred and fifty employees, Pharma D&S Group is PLG's largest build-up to date.
  • PARIS and FLORENCE, Italy, June 7, 2023 /PRNewswire/ -- ProductLife Group (PLG), the global and specialized provider of regulatory, vigilance and quality management services for the Pharmaceutical, Biotech and Medtech industries, announces its intention to merge with Pharma D&S Group, the leading Italian player in the industry.
  • Founded in 2001 by Riccardo Ballerini, Pharma D&S Group grew in 2003 with the arrival of Lino Fabrizi as partner.

PRODUCTLIFE GROUP ANNOUNCES ITS INTENTION TO MERGE WITH PHARMA D&S GROUP, EXPANDING ITS OVERALL OFFERING AND ITALIAN FOOTPRINT

Retrieved on: 
Wednesday, June 7, 2023
DNA, Pharma, Engineering, Medication, Computer, Organization, Biotechnology, PEC, Acquisition, Medtech, Growth, Regulatory affairs, PLG, Fine chemical, Pharmacovigilance

PARIS and FLORENCE, Italy, June 7, 2023 /PRNewswire/ -- ProductLife Group (PLG), the global and specialized provider of regulatory, vigilance and quality management services for the Pharmaceutical, Biotech and Medtech industries, announces its intention to merge with Pharma D&S Group, the leading Italian player in the industry.

Key Points: 
  • ProductLife Group is reaching a key step in its growth with the acquisition of privately owned Italian company Pharma D&S Group.
  • With more than two hundred and fifty employees, Pharma D&S Group is PLG's largest build-up to date.
  • PARIS and FLORENCE, Italy, June 7, 2023 /PRNewswire/ -- ProductLife Group (PLG), the global and specialized provider of regulatory, vigilance and quality management services for the Pharmaceutical, Biotech and Medtech industries, announces its intention to merge with Pharma D&S Group, the leading Italian player in the industry.
  • Founded in 2001 by Riccardo Ballerini, Pharma D&S Group grew in 2003 with the arrival of Lino Fabrizi as partner.

PRODUCTLIFE GROUP ANNOUNCES ITS INTENTION TO MERGE WITH PHARMA D&S GROUP, EXPANDING ITS OVERALL OFFERING AND ITALIAN FOOTPRINT

Retrieved on: 
Tuesday, June 6, 2023
DNA, Pharma, Engineering, Medication, Computer, Organization, Biotechnology, PEC, Acquisition, Medtech, Growth, Regulatory affairs, PLG, Fine chemical, Pharmacovigilance

PARIS and FLORENCE, Italy, June 6, 2023 /PRNewswire/ -- ProductLife Group (PLG), the global and specialized provider of regulatory, vigilance and quality management services for the Pharmaceutical, Biotech and Medtech industries, announces its intention to merge with Pharma D&S Group, the leading Italian player in the industry.

Key Points: 
  • ProductLife Group is reaching a key step in its growth with the acquisition of privately owned Italian company Pharma D&S Group.
  • With more than two hundred and fifty employees, Pharma D&S Group is PLG's largest build-up to date.
  • PARIS and FLORENCE, Italy, June 6, 2023 /PRNewswire/ -- ProductLife Group (PLG), the global and specialized provider of regulatory, vigilance and quality management services for the Pharmaceutical, Biotech and Medtech industries, announces its intention to merge with Pharma D&S Group, the leading Italian player in the industry.
  • Founded in 2001 by Riccardo Ballerini, Pharma D&S Group grew in 2003 with the arrival of Lino Fabrizi as partner.

PRODUCTLIFE GROUP ANNOUNCES ITS INTENTION TO MERGE WITH PHARMA D&S GROUP, EXPANDING ITS OVERALL OFFERING AND ITALIAN FOOTPRINT

Retrieved on: 
Tuesday, June 6, 2023
DNA, Pharma, Engineering, Medication, Computer, Organization, Biotechnology, PEC, Acquisition, Medtech, Growth, Regulatory affairs, PLG, Fine chemical, Pharmacovigilance

PARIS and FLORENCE, Italy, June 6, 2023 /PRNewswire/ -- ProductLife Group (PLG), the global and specialized provider of regulatory, vigilance and quality management services for the Pharmaceutical, Biotech and Medtech industries, announces its intention to merge with Pharma D&S Group, the leading Italian player in the industry.

Key Points: 
  • ProductLife Group is reaching a key step in its growth with the acquisition of privately owned Italian company Pharma D&S Group.
  • With more than two hundred and fifty employees, Pharma D&S Group is PLG's largest build-up to date.
  • PARIS and FLORENCE, Italy, June 6, 2023 /PRNewswire/ -- ProductLife Group (PLG), the global and specialized provider of regulatory, vigilance and quality management services for the Pharmaceutical, Biotech and Medtech industries, announces its intention to merge with Pharma D&S Group, the leading Italian player in the industry.
  • Founded in 2001 by Riccardo Ballerini, Pharma D&S Group grew in 2003 with the arrival of Lino Fabrizi as partner.

Baron & Budd, Douglas & London, P.C., and Napoli Shkolnik Reach Settlement with DuPont and Chemours for PFAS Contamination in America’s Drinking Water

Retrieved on: 
Friday, June 2, 2023
Class Action Lawsuit, Professional Services, Legal, AFFF, P.C, Interim, DuPont, Drinking water, PFAS, Chemours, The Honourable, Douglas, District court, PEC, Soil, Groundwater, Quantification Settlement Agreement, Health, Environment, Plaintiff, Cosmetics, Court

Settling Defendants’ obligation under this Settlement Agreement, is to pay a Settlement Amount of One Billion One Hundred eight-five million dollars ($1,185,000,000).

Key Points: 
  • Settling Defendants’ obligation under this Settlement Agreement, is to pay a Settlement Amount of One Billion One Hundred eight-five million dollars ($1,185,000,000).
  • ; Scott Summy of Baron Budd; and Paul J. Napoli of Napoli Shkolnik – consider this settlement to be in the best interests of class members.
  • This agreement represents the first of many steps to begin to redress the harms of PFAS contamination in America’s drinking water supplies.
  • The agreement does not release any claims beyond those related to PFAS contamination in public water systems’ drinking water.

BioXcel Therapeutics Announces Promising Topline Results from Part 1 of Pivotal SERENITY III Trial of BXCL501 for At-Home Use in Acute Treatment of Agitation in Bipolar Disorders or Schizophrenia

Retrieved on: 
Thursday, May 25, 2023
Yale School of Medicine, Bradycardia, Orthostatic hypotension, Dexmedetomidine, Somnolence, Schizophrenia, Xerostomia, Hypotension, Safety, Tolerability, Yale school, BS 5839 Part 1, II, Șaeș, Alignment, Incidence, PEC, Dizziness, Patient, Translational research, Psychiatry, Artificial intelligence, FDA, Therapy, Agitation, Bipolar disorder, Caregiver, DSM-IV codes, Vaccine, Pharmaceutical industry, Part

BXCL501 would represent the first-ever FDA approved therapy for at-home use in this indication, if approved.

Key Points: 
  • BXCL501 would represent the first-ever FDA approved therapy for at-home use in this indication, if approved.
  • SERENITY III is a two-part, double-blinded, placebo-controlled pivotal study designed to evaluate BXCL501 in acutely agitated adult patients with bipolar disorders or schizophrenia for at-home use.
  • Although the primary efficacy endpoint was not statistically significant at 2 hours (p=0.077), BXCL501 separated from placebo at 4 hours (p=0.049).
  • These data provide a clear path for initiating SERENITY III Part 2, to pursue approval in the at-home setting.

New CISA Zero Trust Maturity Model Brings Attention to Encryption-in-Use Solutions

Retrieved on: 
Wednesday, May 24, 2023
SAFE, Model, Cybersecurity and Infrastructure Security Agency, Privacy, CISA, Maturity model, Organization, AES256, Motion, PEC, Computer security, Data, Mathematical optimization, Zero trust security model, Government, Cryptocurrency, Computer data storage, Paper clip, Education minister

HACKENSACK, N.J., May 24, 2023 (GLOBE NEWSWIRE) -- Paperclip, Inc. (OTCMKTS:PCPJ) announces that its Paperclip SAFE® solution can help organizations align with the Cybersecurity and Infrastructure Security Agency (CISA) updated Zero Trust Maturity Model released last month.

Key Points: 
  • HACKENSACK, N.J., May 24, 2023 (GLOBE NEWSWIRE) -- Paperclip, Inc. (OTCMKTS:PCPJ) announces that its Paperclip SAFE® solution can help organizations align with the Cybersecurity and Infrastructure Security Agency (CISA) updated Zero Trust Maturity Model released last month.
  • “It is the first compliance body to recommend this encryption technique to address the vulnerability related to searchable data.
  • The Zero Trust Maturity Model version 2 includes four stages of maturity: Traditional, Initial, Advanced, and Optimal.
  • According to CISA, the Zero Trust Maturity Model furthers the federal government’s continued progress toward a zero trust approach to cybersecurity.

Paperclip and Securadin Partner to Align Security Innovation with Evolving Compliance

Retrieved on: 
Tuesday, May 9, 2023
Data management, Partnership, SAFE, Paper clip, CISA, Research, Privacy, Organization, PEC, Risk, Memory, Cryptocurrency, Risk management, Online shopping

Paperclip SAFE® searchable encryption solution ensures comprehensive data security for these businesses while meeting and exceeding the latest compliance requirements focused on privacy, access controls, and data-in-use encryption.

Key Points: 
  • Paperclip SAFE® searchable encryption solution ensures comprehensive data security for these businesses while meeting and exceeding the latest compliance requirements focused on privacy, access controls, and data-in-use encryption.
  • “We know that compliance drives the biggest shifts in security, and organizations like Securadin are paramount to assessing risk and aligning compliance to security,” said Chad Walter, Chief Revenue Officer at Paperclip .
  • Through this partnership, Securadin clients will now have an option that greatly improves their data security posture and compliance positioning.
  • Under the new Zero Trust Security Model , CISA has determined that encryption of usable data is required under the optimal data security model.

Vishay Intertechnology to Showcase Latest Power Management Solutions for Next-Generation Applications at PCIM Europe 2023

Retrieved on: 
Thursday, May 4, 2023
DNA, Automotive Grade Linux, Exhibition, Electronics, Telecommunications, DC, AC, ENYCAP, App Store (iOS/iPadOS), Silicon carbide, Renewable energy, PEC, VSH, MOSFET, Vehicle registration plates of Nepal, Danger Rangers, FRED, Power metal, NYSE, Gallium nitride, ESTA, 2L, Vishay Intertechnology

MALVERN, Pa., May 04, 2023 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today announced that at PCIM Europe 2023, the company will be showcasing its broad portfolio of power management solutions that address two increasingly important trends in power electronics: e-mobility and energy storage.

Key Points: 
  • MALVERN, Pa., May 04, 2023 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today announced that at PCIM Europe 2023, the company will be showcasing its broad portfolio of power management solutions that address two increasingly important trends in power electronics: e-mobility and energy storage.
  • PCIM Europe 2023 — an exhibition for power electronics, intelligent motion, renewable energy, and energy management — will be taking place May 9-11 at the Messe Nuremberg, Germany.
  • Serving customers worldwide, Vishay is The DNA of tech.™ Vishay Intertechnology, Inc. is a Fortune 1,000 Company listed on the NYSE (VSH).
  • Power Metal Plate and ENYCAP are trademarks and FRED Pt, Power Metal Strip, eSMP, and TMBS are registered trademarks of Vishay Intertechnology.